- Morningstar•3 hours ago
The Dow Jones Industrial Average and S&P 500 were looking to extend their gains, but declines in crude-oil prices and the healthcare sector have kept investors wary. The Nasdaq Biotechnology Index has been plummeting and may finish the day with its worst decline since early October. Healthcare shares fell after President-elect Donald Trump threatened to cut drug prices.
- Market Realist•3 hours ago
The founder and president of Greenlight Capital, David Einhorn, discussed his investment ideas at the Robin Hood Investors Conference.
- The Wall Street Journal•3 hours ago
Pfizer Inc. and Merck & Co. led the Dow Jones Industrial Average lower, dropping 2.7% apiece. The $2.8 billion SPDR S&P Biotech exchange-traded fund, which tracks a basket of stocks including Celgene Corp. ...
MRK : Summary for Merck & Company, Inc. Common St - Yahoo Finance
Merck & Co., Inc. (MRK)
NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
|Bid||59.95 x 900|
|Ask||59.96 x 400|
|Day's Range||58.62 - 60.02|
|52 Week Range||47.97 - 65.46|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||30.59|
|Dividend & Yield||1.88 (3.08%)|
|1y Target Est||N/A|